CC
HOLX

CIBRA Capital’s Hologic HOLX Stock Holding History

CIBRA Capital’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Buy
208,996
+146,158
+233% +$11M 7.62% 5
2025
Q4 		$4.68M Buy
+62,838
New +$4.59M 8.04% 6

Other funds holding HOLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

CIBRA Capital's HOLX Position: Q1 2026 in Review

CIBRA Capital increased its Hologic (HOLX) stake by 233% in Q1 2026, buying an estimated $11M and bringing the position to 208,996 shares worth $15.8M. The position accounts for 7.62% of the portfolio, ranked #5.

CIBRA Capital first reported a position in HOLX in Q4 2025 and has held it in 2 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • CIBRA Capital held 208,996 shares of Hologic worth $15.8M as of Q1 2026.
  • CIBRA Capital bought 146,158 Hologic shares in Q1 2026, an estimated $11M.
  • Hologic made up 7.62% of CIBRA Capital's portfolio in Q1 2026, its #5 holding.
  • CIBRA Capital first reported a position in Hologic in Q4 2025 and has held it in 2 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on CIBRA Capital's 13F filing for Q1 2026, filed 24 Apr 2026.